 |
인쇄하기
취소
|
KFDA to approve GSK's new anesthetic drug, Ultiva
KFDA approved GSK's new anesthetic drug, Ultiva at the end of April.
Ultiva (Remifentanil Hcl) was first approved as a new systemic anesthetic drug in 1996 and its additional indications for a sedative analgesia was approved in Europe in March 2002. It shows many advantages for the physician to adjust its dose and for the patients rapidly to recover from the anesthesia. Unlike other analgesi...
Ultiva (Remifentanil Hcl) was first approved as a new systemic anesthetic drug in 1996 and its additional indications for a sedative analgesia was approved in Europe in March 2002. It shows many advantages for the physician to adjust its dose and for the patients rapidly to recover from the anesthesia. Unlike other analgesi...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.